Renal replacement therapy in acute kidney injury: controversy and consensus
详细信息 查看全文
- 作者：Claudio Ronco (1)
Zaccaria Ricci (2)
Daniel De Backer (3)
John A Kellum (4)
Fabio S Taccone (3)
Michael Joannidis (5)
Peter Pickkers (6)
Vincenzo Cantaluppi (7)
Franco Turani (8)
Patrick Saudan (9)
Rinaldo Bellomo (10)
Olivier Joannes-Boyau (11)
Massimo Antonelli (12)
Didier Payen (13)
John R Prowle (14)
Jean-Louis Vincent (3)
1. Department Nephrology Dialysis & Transplantation ; International Renal Research Institute (IRRIV) ; San Bortolo Hospital ; Viale Rodolfi ; 36100 ; Vicenza ; Italy
2. Department of Cardiology and Cardiac Surgery ; Pediatric Cardiac Intensive Care Unit ; Bambino Ges霉 Children鈥檚 Hospital ; IRCCS ; Piazza S. Onofrio 4 ; 00165 ; Rome ; Italy
3. Department of Intensive Care ; Erasme Hospital ; Universit茅 libre de Bruxelles ; Route de Lennik 808 ; 1070 ; Brussels ; Belgium
4. Center for Critical Care Nephrology ; Department of Critical Care Medicine ; University of Pittsburgh ; 3550 Terrace Street ; Pittsburgh ; PA ; 15261 ; USA
5. Division of Emergency and Intensive Care Medicine ; Department of Internal Medicine ; Medical University of Innsbruck ; Anichstra脽e 35 ; 6020 ; Innsbruck ; Austria
6. Department of Intensive Care Medicine ; Radboud University Medical Centre ; PO Box 9101 ; 6500 ; HB ; Nijmegen ; The Netherlands
7. Nephrology ; Dialysis and Kidney Transplantation Unit ; University of Torino ; Azienda Ospedaliera Universitaria 鈥楥itt脿 della Salute e della Scienza di Torino Presidio Molinette鈥? Corso Bramante 88 ; 10126 ; Turin ; Italy
8. Department of Intensive Care ; Aurelia Hospital and European Hospital ; Via Portuense 694 ; 00416 ; Rome ; Italy
9. Service of Nephrology ; Department of Internal Medicine Specialties ; University Hospital of Geneva ; 4 rue Gabrielle Perret-Gentil ; CH 1211 ; Geneva ; Switzerland
10. Department of Intensive Care ; Austin Hospital ; 145 Studley Road ; Heidelberg ; Melbourne ; VIC ; 3084 ; Australia
11. Centre Hospitalier Universitaire (CHU) de Bordeaux ; Service d鈥橝nesth茅sie-R茅animation 2 ; Avenue de Magellan ; F-33600 ; Pessac ; France
12. Universit脿 Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli ; Largo Agostino Gemelli 8 ; 00168 ; Rome ; Italy
13. Department of Anesthesiology and Critical Care ; Lariboisi猫re Hospital ; Assistance Publique-H么pitaux de Paris ; University of Paris ; 7 Denis Diderot ; 75475 ; Paris ; Cedex 10 ; France
14. Adult Critical Care Unit ; The Royal London Hospital ; Barts Health ; Whitechapel Road ; London ; E1 1BB ; UK - 刊名：Critical Care
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：19
- 期：1
- 全文大小：587 KB
- 参考文献：1. Bellomo, R, Ronco, C Continuous renal replacement therapy: hemofiltration, hemodiafiltration or hemodialysis. In: Ronco, C, Bellomo, R, Kellum, JA eds. (2009) Critcal Care Nephrology. Saunders Elsevier, Philadelphia, pp. 1354-1358
KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl 2: pp. 1-138
2. Ward, D Principles of extracorporeal circulation. In: Ronco, C, Bellomo, R, Kellum, JA eds. (2009) Critical Care Nephrology. Elsevier Saunders, Philadelphia, pp. 1141-1145
3. Baldwin, I, Bellomo, R, Koch, B (2004) Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Med 30: pp. 2074-2079
4. Vijayan, A (2009) Vascular access for continuous renal replacement therapy. Semin Dial 22: pp. 133-136
5. Parienti, JJ, Thirion, M, Megarbane, B, Souweine, B, Ouchikhe, A, Polito, A, Forel, JM, Marque, S, Misset, B, Airapetian, N, Daurel, C, Mira, JP, Ramakers, M, Cheyron, D, Coutour, X, Daubin, C, Charbonneau, P (2008) Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299: pp. 2413-2422
6. Parienti, JJ, Megarbane, B, Fischer, MO, Lautrette, A, Gazui, N, Marin, N, Hanouz, JL, Ramakers, M, Daubin, C, Mira, JP, Charbonneau, P, Cheyron, D (2010) Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 38: pp. 1118-1125
7. Morgan, D, Ho, K, Murray, C, Davies, H, Louw, J (2012) A randomized trial of catheters of different lengths to achieve right atrium versus superior vena cava placement for continuous renal replacement therapy. Am J Kidney Dis 60: pp. 272-279
8. Ricci, Z, Ronco, C (2005) Pre- versus post-dilution CVVH. Blood Purif 23: pp. 338
9. Payen, D, Pont, AC, Sakr, Y, Spies, C, Reinhart, K, Vincent, JL (2008) A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 12: pp. R74
10. House, AA, Haapio, M, Lentini, P, Bobek, I, Cal, M, Cruz, DN, Virzi, GM, Carraro, R, Gallo, G, Piccinni, P, Ronco, C (2011) Volume assessment in mechanically ventilated critical care patients using bioimpedance vectorial analysis, brain natriuretic peptide, and central venous pressure. Int J Nephrol 2011: pp. 413760
11. Ronco, C, Kaushik, M, Valle, R, Aspromonte, N, Peacock, WF (2012) Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the 鈥?B鈥?approach. Semin Nephrol 32: pp. 129-141
12. Hoste, EA, Maitland, K, Brudney, CS, Mehta, R, Vincent, JL, Yates, D, Kellum, JA, Mythen, MG, Shaw, AD (2014) Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 113: pp. 740-747
13. Bellomo, R, Kellum, JA, Ronco, C (2012) Acute kidney injury. Lancet 380: pp. 756-766
14. Srisawat, N, Murugan, R, Lee, M, Kong, L, Carter, M, Angus, DC, Kellum, JA (2011) Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int 80: pp. 545-552
15. Srisawat, N, Wen, X, Lee, M, Kong, L, Elder, M, Carter, M, Unruh, M, Finkel, K, Vijayan, A, Ramkumar, M, Paganini, E, Singbartl, K, Palevsky, PM, Kellum, JA (2011) Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol 6: pp. 1815-1823
16. Chawla, LS, Davison, DL, Brasha-Mitchell, E, Koyner, JL, Arthur, JM, Shaw, AD, Tumlin, JA, Trevino, SA, Kimmel, PL, Seneff, MG (2013) Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 17: pp. R207
17. Honore, PM, Jamez, J, Wauthier, M, Lee, PA, Dugernier, T, Pirenne, B, Hanique, G, Matson, JR (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: pp. 3581-3587
18. Payen, D, Mateo, J, Cavaillon, JM, Fraisse, F, Floriot, C, Vicaut, E (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37: pp. 803-810
19. Karvellas, CJ, Farhat, MR, Sajjad, I, Mogensen, SS, Leung, AA, Wald, R, Bagshaw, SM (2011) A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 15: pp. R72
20. Leite, TT, Macedo, E, Pereira, SM, Bandeira, SR, Pontes, PH, Garcia, AS, Militao, FR, Sobrinho, IM, Assuncao, LM, Liborio, AB (2013) Timing of renal replacement therapy initiation by AKIN classification system. Crit Care 17: pp. R62
21. Clec鈥檋, C, Darmon, M, Lautrette, A, Chemouni, F, Azoulay, E, Schwebel, C, Dumenil, AS, Garrouste-Org, , Goldgran-Toledano, D, Cohen, Y, Timsit, JF (2012) Efficacy of renal replacement therapy in critically ill patients: a propensity analysis. Crit Care 16: pp. R236
22. Bellomo, R, Cass, A, Cole, L, Finfer, S, Gallagher, M, Lee, J, Lo, S, McArthur, C, McGuiness, S, Norton, R, Myburgh, J, Scheinkestel, C, Su, S (2012) An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs Augmented Level of Replacement Therapy trial. Crit Care Med 40: pp. 1753-1760
23. Wu, VC, Ko, WJ, Chang, HW, Chen, YW, Lin, YF, Shiao, CC, Chen, YM, Chen, YS, Tsai, PR, Hu, FC, Wang, JY, Lin, YH, Wu, KD (2008) Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med 34: pp. 101-108
24. Uchino, S, Bellomo, R, Morimatsu, H, Morgera, S, Schetz, M, Tan, I, Bouman, C, Macedo, E, Gibney, N, Tolwani, A, Straaten, HO, Ronco, C, Kellum, JA (2009) Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 37: pp. 2576-2582
25. Voort, PH, Boerma, E, Pickkers, P (2014) The furosemide stress test to predict renal function after continuous renal replacement therapy. Crit Care 18: pp. 429
26. Voort, PH, Boerma, EC, Koopmans, M, Zandberg, M, Ruiter, J, Gerritsen, RT, Egbers, PH, Kingma, WP, Kuiper, MA (2009) Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med 37: pp. 533-538
27. Mishra, J, Dent, C, Tarabishi, R, Mitsnefes, MM, Ma, Q, Kelly, C, Ruff, SM, Zahedi, K, Shao, M, Bean, J, Mori, K, Barasch, J, Devarajan, P (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: pp. 1231-1238
28. Geus, HR, Betjes, MG, Bakker, J (2010) Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients. Intensive Care Med 36: pp. 2156-2157
29. Palevsky, PM, Zhang, JH, O鈥機onnor, TZ, Chertow, GM, Crowley, ST, Choudhury, D, Finkel, K, Kellum, JA, Paganini, E, Schein, RM, Smith, MW, Swanson, KM, Thompson, BT, Vijayan, A, Watnick, S, Star, RA, Peduzzi, P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: pp. 7-20
30. Schneider, AG, Bellomo, R, Bagshaw, SM, Glassford, NJ, Lo, S, Jun, M, Cass, A, Gallagher, M (2013) Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 39: pp. 987-997
31. Srisawat, N, Lawsin, L, Uchino, S, Bellomo, R, Kellum, JA (2010) Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care 14: pp. R46
32. Manns, B, Doig, CJ, Lee, H, Dean, S, Tonelli, M, Johnson, D, Donaldson, C (2003) Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med 31: pp. 449-455
33. Wald, R, Shariff, SZ, Adhikari, NK, Bagshaw, SM, Burns, KE, Friedrich, JO, Garg, AX, Harel, Z, Kitchlu, A, Ray, JG (2014) The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Crit Care Med 42: pp. 868-877
34. Berbece, AN, Richardson, RM (2006) Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int 70: pp. 963-968
35. Kumar, VA, Craig, M, Depner, TA, Yeun, JY (2000) Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 36: pp. 294-300
36. Wu, VC, Wang, CH, Wang, WJ, Lin, YF, Hu, FC, Chen, YW, Chen, YS, Wu, MS, Lin, YH, Kuo, CC, Huang, TM, Chen, YM, Tsai, PR, Ko, WJ, Wu, KD (2010) Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failure. Am J Surg 199: pp. 466-476
37. Kielstein, JT, Kretschmer, U, Ernst, T, Hafer, C, Bahr, MJ, Haller, H, Fliser, D (2004) Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 43: pp. 342-349
38. Schwenger, V, Weigand, MA, Hoffmann, O, Dikow, R, Kihm, LP, Seckinger, J, Miftari, N, Schaier, M, Hofer, S, Haar, C, Nawroth, PP, Zeier, M, Martin, E, Morath, C (2012) Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care 16: pp. R140
39. Faulhaber-Walter, R, Hafer, C, Jahr, N, Vahlbruch, J, Hoy, L, Haller, H, Fliser, D, Kielstein, JT (2009) The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 24: pp. 2179-2186
40. Ronco, C, Bellomo, R, Homel, P, Brendolan, A, Dan, M, Piccinni, P, Greca, G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: pp. 26-30
41. Legrand, M, Darmon, M, Joannidis, M, Payen, D (2013) Management of renal replacement therapy in ICU patients: an international survey. Intensive Care Med 39: pp. 101-108
42. Bellomo, R, Cass, A, Cole, L, Finfer, S, Gallagher, M, Lo, S, McArthur, C, McGuinness, S, Myburgh, J, Norton, R, Scheinkestel, C, Su, S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361: pp. 1627-1638
43. Wen, X, Murugan, R, Kong, L, Shan, N, Lee, MJ, Carter, MJ, Elder, M, Palevsky, PM, Unruh, M, Kellum, JA (2011) Differential effects of renal replacement therapy on plasma inflammatory and apoptotic biomarkers in acute kidney injury [abstract]. J Am Soc Nephrol 22: pp. 206A
44. Murugan, R, Wen, X, Shah, N, Lee, M, Kong, L, Pike, F, Keener, C, Unruh, M, Finkel, K, Vijayan, A, Palevsky, PM, Paganini, E, Carter, M, Elder, M, Kellum, JA (2014) Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol Dial Transplant 29: pp. 1854-1864
45. Payen, D, Lukaszewicz, AC, Legrand, M, Gayat, E, Faivre, V, Megarbane, B, Azoulay, E, Fieux, F, Charron, D, Loiseau, P, Busson, M (2012) A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLoS One 7: pp. e35838
46. Btaiche, IF, Mohammad, RA, Alaniz, C, Mueller, BA (2008) Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Pharmacotherapy 28: pp. 600-613
47. Geerse, DA, Bindels, AJ, Kuiper, MA, Roos, AN, Spronk, PE, Schultz, MJ (2010) Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 14: pp. R147
48. Ricci, Z, Salvatori, G, Bonello, M, Ratanarat, R, Andrikos, E, Dan, M, Piccinni, P, Ronco, C (2005) A new machine for continuous renal replacement therapy: from development to clinical testing. Expert Rev Med Devices 2: pp. 47-55
49. Hiremath, S, Slivar, S, Magner, P (2013) Phosphate balance with continuous renal replacement therapy: a simple solution. Am J Kidney Dis 62: pp. 644
50. Chua, HR, Schneider, AG, Baldwin, I, Collins, A, Ho, L, Bellomo, R (2013) Phoxilium vs Hemosol-B0 for continuous renal replacement therapy in acute kidney injury. J Crit Care 884: pp. e7-e14
51. Weber, CF, Gorlinger, K, Meininger, D, Herrmann, E, Bingold, T, Moritz, A, Cohn, LH, Zacharowski, K (2012) Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117: pp. 531-547
52. Holt, AW, Bierer, P, Glover, P, Plummer, JL, Bersten, AD (2002) Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits. Intensive Care Med 28: pp. 1649-1655
53. Hirsh, J, Warkentin, TE, Shaughnessy, SG, Anand, SS, Halperin, JL, Raschke, R, Granger, C, Ohman, EM, Dalen, JE (2001) Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119: pp. 64S-94S
54. Joannidis, M, Oudemans-van Straaten, HM (2007) Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 11: pp. 218
55. Oudemans-van Straaten, HM, Wester, JP, Pont, AC, Schetz, MR (2006) Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?. Intensive Care Med 32: pp. 188-202
56. Wetering, J, Westendorp, RG, Hoeven, JG, Stolk, B, Feuth, JD, Chang, PC (1996) Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 7: pp. 145-150
57. Cheyron, D, Bouchet, B, Bruel, C, Daubin, C, Ramakers, M, Charbonneau, P (2006) Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case鈥揷ontrol study. Crit Care 10: pp. R45
58. Joannidis, M, Kountchev, J, Rauchenzauner, M, Schusterschitz, N, Ulmer, H, Mayr, A, Bellmann, R (2007) Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study. Intensive Care Med 33: pp. 1571-1579
59. Greaves, M (2002) Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 87: pp. 163-164
60. Selleng, K, Warkentin, TE, Greinacher, A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35: pp. 1165-1176
61. Oudemans-van Straaten, HM, Kellum, JA, Bellomo, R (2011) Clinical review: anticoagulation for continuous renal replacement therapy - heparin or citrate?. Crit Care 15: pp. 202
62. Lanckohr, C, Hahnenkamp, K, Boschin, M (2013) Continuous renal replacement therapy with regional citrate anticoagulation: do we really know the details?. Curr Opin Anaesthesiol 26: pp. 428-437
63. Tolwani, A, Wille, KM (2012) Advances in continuous renal replacement therapy: citrate anticoagulation update. Blood Purif 34: pp. 88-93
64. Hetzel, GR, Schmitz, M, Wissing, H, Ries, W, Schott, G, Heering, PJ, Isgro, F, Kribben, A, Himmele, R, Grabensee, B, Rump, LC (2011) Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 26: pp. 232-239
65. Oudemans-van Straaten, HM, Bosman, RJ, Koopmans, M, Voort, PH, Wester, JP, Spoel, JI, Dijksman, LM, Zandstra, DF (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37: pp. 545-552
66. Morabito, S, Pistolesi, V, Tritapepe, L, Zeppilli, L, Polistena, F, Strampelli, E, Pierucci, A (2012) Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care 16: pp. R111
67. Gritters, M, Grooteman, MP, Schoorl, M, Schoorl, M, Bartels, PC, Scheffer, PG, Teerlink, T, Schalkwijk, CG, Spreeuwenberg, M, Nube, MJ (2006) Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 21: pp. 153-159
68. Gabutti, L, Ferrari, N, Mombelli, G, Keller, F, Marone, C (2004) The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation. J Nephrol 17: pp. 819-825
69. Bournazos, S, Rennie, J, Hart, SP, Dransfield, I (2008) Choice of anticoagulant critically affects measurement of circulating platelet-leukocyte complexes. Arterioscler Thromb Vasc Biol 28: pp. e2-e3
70. Schilder, L, Nurmohamed, S, Bosch, FH, Purmer, IM, Boer, SS, Kleppe, CG, Vervloet, MG, Beishuizen, A, Girbes, A, Wee, PM, Groeneveld, A (2014) Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care 18: pp. 472
71. Lameire, N, Kellum, JA (2013) Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Crit Care 17: pp. 205
72. Blot, S, Lipman, J, Roberts, DM, Roberts, JA (2014) The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?. Diagn Microbiol Infect Dis 79: pp. 77-84
73. Roberts, DM, Roberts, JA, Roberts, MS, Liu, X, Nair, P, Cole, L, Lipman, J, Bellomo, R (2012) Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 40: pp. 1523-1528
74. Hites, M, Dell鈥橝nna, AM, Scolletta, S, Taccone, FS (2014) The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients. Adv Drug Deliv Rev 77C: pp. 21
75. Beumier, M, Roberts, JA, Kabtouri, H, Hites, M, Cotton, F, Wolff, F, Lipman, J, Jacobs, F, Vincent, JL, Taccone, FS (2013) A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy. J Antimicrob Chemother 68: pp. 2859-2865
76. Taccone, FS, Backer, D, Laterre, PF, Spapen, H, Dugernier, T, Delattre, I, Wallemacq, P, Vincent, JL, Jacobs, F (2011) Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy. Int J Antimicrob Agents 37: pp. 531-535
77. Jamal, JA, Udy, AA, Lipman, J, Roberts, JA (2014) The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens. Crit Care Med 42: pp. 1640-1650
78. Seyler, L, Cotton, F, Taccone, FS, Backer, D, Macours, P, Vincent, JL, Jacobs, F (2011) Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 15: pp. R137
79. Beumier, M, Casu, GS, Hites, M, Seyler, L, Cotton, F, Vincent, JL, Jacobs, F, Taccone, FS (2014) beta-lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care 18: pp. R105
80. Zarjou, A, Agarwal, A (2011) Sepsis and acute kidney injury. J Am Soc Nephrol 22: pp. 999-1006
81. Joannes-Boyau, O, Honore, PM, Perez, P, Bagshaw, SM, Grand, H, Canivet, JL, Dewitte, A, Flamens, C, Pujol, W, Grandoulier, AS, Fleureau, C, Jacobs, R, Broux, C, Floch, H, Branchard, O, Franck, S, Roze, H, Collin, V, Boer, W, Calderon, J, Gauche, B, Spapen, HD, Janvier, G, Ouattara, A (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39: pp. 1535-1546
82. Zhang, P, Yang, Y, Lv, R, Zhang, Y, Xie, W, Chen, J (2012) Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant 27: pp. 967-973
83. Lehner, GF, Wiedermann, CJ, Joannidis, M (2014) High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis. Minerva Anestesiol 80: pp. 595-609
84. Kellum, JA, Kong, L, Fink, MP, Weissfeld, LA, Yealy, DM, Pinsky, MR, Fine, J, Krichevsky, A, Delude, RL, Angus, DC (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167: pp. 1655-1663
85. Atan, R, Crosbie, D, Bellomo, R (2012) Techniques of extracorporeal cytokine removal: a systematic review of the literature. Blood Purif 33: pp. 88-100
86. Atan, R, Crosbie, DC, Bellomo, R (2013) Techniques of extracorporeal cytokine removal: a systematic review of human studies. Ren Fail 35: pp. 1061-1070
87. Haase, M, Bellomo, R, Morgera, S, Baldwin, I, Boyce, N (2007) High cut-off point membranes in septic acute renal failure: a systematic review. Int J Artif Organs 30: pp. 1031-1041
88. Ronco, C, Brendolan, A, Lonnemann, G, Bellomo, R, Piccinni, P, Digito, A, Dan, M, Irone, M, Greca, G, Inguaggiato, P, Maggiore, U, Nitti, C, Wratten, ML, Ricci, Z, Tetta, C (2002) A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30: pp. 1250-1255
89. Livigni, S, Bertolini, G, Rossi, C, Ferrari, F, Giardino, M, Pozzato, M, Remuzzi, G (2014) Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial. BMJ Open 4: pp. e003536
90. Kushi, H, Miki, T, Sakagami, Y, Sato, J, Saito, T, Tanjoh, K (2009) Hemoperfusion with an immobilized polymyxin B fiber column decreases macrophage and monocyte activity. Ther Apher Dial 13: pp. 515-519
91. Cantaluppi, V, Assenzio, B, Pasero, D, Romanazzi, GM, Pacitti, A, Lanfranco, G, Puntorieri, V, Martin, EL, Mascia, L, Monti, G, Casella, G, Segoloni, GP, Camussi, G, Ranieri, VM (2008) Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 34: pp. 1638-1645
92. Cruz, DN, Perazella, MA, Bellomo, R, Cal, M, Polanco, N, Corradi, V, Lentini, P, Nalesso, F, Ueno, T, Ranieri, VM, Ronco, C (2007) Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 11: pp. R47
93. Zhou, F, Peng, Z, Murugan, R, Kellum, JA (2013) Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 41: pp. 2209-2220
94. Cruz, DN, Antonelli, M, Fumagalli, R, Foltran, F, Brienza, N, Donati, A, Malcangi, V, Petrini, F, Volta, G, Bobbio Pallavicini, FM, Rottoli, F, Giunta, F, Ronco, C (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301: pp. 2445-2452
95. Damman, K, Deursen, VM, Navis, G, Voors, AA, Veldhuisen, DJ, Hillege, HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53: pp. 582-588
96. Mullens, W, Abrahams, Z, Francis, GS, Sokos, G, Taylor, DO, Starling, RC, Young, JB, Tang, WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: pp. 589-596
97. Costanzo, MR, Guglin, ME, Saltzberg, MT, Jessup, ML, Bart, BA, Teerlink, JR, Jaski, BE, Fang, JC, Feller, ED, Haas, GJ, Anderson, AS, Schollmeyer, MP, Sobotka, PA (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49: pp. 675-683
98. Bart, BA, Goldsmith, SR, Lee, KL, Givertz, MM, O鈥機onnor, CM, Bull, DA, Redfield, MM, Deswal, A, Rouleau, JL, LeWinter, MM, Ofili, EO, Stevenson, LW, Semigran, MJ, Felker, GM, Chen, HH, Hernandez, AF, Anstrom, KJ, McNulty, SE, Velazquez, EJ, Ibarra, JC, Mascette, AM, Braunwald, E (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367: pp. 2296-2304
99. Patarroyo, M, Wehbe, E, Hanna, M, Taylor, DO, Starling, RC, Demirjian, S, Tang, WH (2012) Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol 60: pp. 1906-1912
100. Hemmer, M, Viquerat, CE, Suter, PM, Vallotton, MB (1980) Urinary antidiuretic hormone excretion during mechanical ventilation and weaning in man. Anesthesiology 52: pp. 395-400
101. Murugan, R, Karajala-Subramanyam, V, Lee, M, Yende, S, Kong, L, Carter, M, Angus, DC, Kellum, JA (2010) Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 77: pp. 527-535
102. Hoke, TS, Douglas, IS, Klein, CL, He, Z, Fang, W, Thurman, JM, Tao, Y, Dursun, B, Voelkel, NF, Edelstein, CL, Faubel, S (2007) Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 18: pp. 155-164
103. Dellinger, RP, Levy, MM, Rhodes, A, Annane, D, Gerlach, H, Opal, SM, Sevransky, JE, Sprung, CL, Douglas, IS, Jaeschke, R, Osborn, TM, Nunnally, ME, Townsend, SR, Reinhart, K, Kleinpell, RM, Angus, DC, Deutschman, CS, Machado, FR, Rubenfeld, GD, Webb, S, Beale, RJ, Vincent, JL, Moreno, R (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39: pp. 165-228
104. Forster, C, Schriewer, J, John, S, Eckardt, KU, Willam, C (2013) Low-flow CO(2) removal integrated into a renal-replacement circuit can reduce acidosis and decrease vasopressor requirements. Crit Care 17: pp. R154
105. Burki, NK, Mani, RK, Herth, FJ, Schmidt, W, Teschler, H, Bonin, F, Becker, H, Randerath, WJ, Stieglitz, S, Hagmeyer, L, Priegnitz, C, Pfeifer, M, Blaas, SH, Putensen, C, Theuerkauf, N, Quintel, M, Moerer, O (2013) A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 143: pp. 678-686
106. Zacharia, BE, Ducruet, AF, Hickman, ZL, Grobelny, BT, Fernandez, L, Schmidt, JM, Narula, R, Ko, LN, Cohen, ME, Mayer, SA, Connolly, ES (2009) Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study. Stroke 40: pp. 2375-2381
107. Corral, L, Javierre, CF, Ventura, JL, Marcos, P, Herrero, JI, Manez, R (2012) Impact of non-neurological complications in severe traumatic brain injury outcome. Crit Care 16: pp. R44
108. Liu, M, Liang, Y, Chigurupati, S, Lathia, JD, Pletnikov, M, Sun, Z, Crow, M, Ross, CA, Mattson, MP, Rabb, H (2008) Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 19: pp. 1360-1370
109. Ronco, C, Bellomo, R, Brendolan, A, Pinna, V, Greca, G (1999) Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol 12: pp. 173-178
110. Davenport, A, Will, EJ, Davison, AM (1990) Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant 5: pp. 192-198
111. Ko, SB, Choi, HA, Gilmore, E, Schmidt, JM, Claassen, J, Lee, K, Mayer, SA, Badjatia, N (2012) Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation. Neurology 78: pp. e36-e38
112. Benz-Worner, J, Haberthur, C, Kothbauer, K (2011) Fluid and electrolyte management of acute traumatic brain injury using hemofiltration with regional citrate anticoagulation. J Neurosurg Anesthesiol 23: pp. 266-267
113. Kelleher, JA, Chan, TY, Chan, PH, Gregory, GA (1996) Protection of astrocytes by fructose 1,6-bisphosphate and citrate ameliorates neuronal injury under hypoxic conditions. Brain Res 726: pp. 167-173
114. Lindhoff-Last, E, Betz, C, Bauersachs, R (2001) Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients. Clin Appl Thromb Hemost 7: pp. 300-304
115. Pont, AC, Hofstra, JJ, Pik, DR, Meijers, JC, Schultz, MJ (2007) Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study. Crit Care 11: pp. R102
116. Link, A, Girndt, M, Selejan, S, Mathes, A, Bohm, M, Rensing, H (2009) Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 37: pp. 105-110
117. Kiser, TH, MacLaren, R, Fish, DN, Hassell, KL, Teitelbaum, I (2010) Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy 30: pp. 1117-1126
118. Kiser, TH, Fish, DN (2006) Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction. Pharmacotherapy 26: pp. 452-460 - 刊物主题：Intensive / Critical Care Medicine; Emergency Medicine;
- 出版者：BioMed Central
- ISSN：1364-8535
文摘
Renal replacement therapies (RRTs) represent a cornerstone in the management of severe acute kidney injury. This area of intensive care and nephrology has undergone significant improvement and evolution in recent years. Continuous RRTs have been a major focus of new technological and treatment strategies. RRT is being used increasingly in the intensive care unit, not only for renal indications but also for other organ-supportive strategies. Several aspects related to RRT are now well established, but others remain controversial. In this review, we review the available RRT modalities, covering technical and clinical aspects. We discuss several controversial issues, provide some practical recommendations, and where possible suggest a research agenda for the future.